HighCape Capital, LLC Insider Profile

4 Followers
HighCape Capital, LLC, Ten Percent Owner at Aziyo Biologics, holds 7.00M shares in Aziyo Biologics (Ticker: ELUT).
tipranks
HighCape Capital, LLC

HighCape Capital, LLC
Aziyo Biologics (ELUT)
Ten Percent Owner

Not Ranked
HighCape Capital, LLC has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$23M
100.00%
A breakdown of HighCape Capital, LLC's holdings

Insider Roles

Aziyo Biologics
(ELUT)
Ten Percent Owner
Roles that HighCape Capital, LLC holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by HighCape Capital, LLC

HighCape Capital, LLC's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aziyo Biologics
Jan 08, 2024
Ten Percent Owner
Uninformative Sell
$22.68M
HighCape Capital, LLC has not reported any informative transactions for ELUT, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 05, 2023
Uninformative Buy
$0.00
-
$0.00
Jan 08, 2024
Uninformative Sell
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see HighCape Capital, LLC's performance on stock

HighCape Capital, LLC insider profile FAQ

What is the percentage of profitable transactions made by HighCape Capital, LLC?
The percentage of profitable transactions made by HighCape Capital, LLC is ―.
    What is the average return per transaction made by HighCape Capital, LLC?
    The average return per transaction made by HighCape Capital, LLC is ―.
      What stocks does HighCape Capital, LLC hold?
      HighCape Capital, LLC holds: ELUT stocks.
        What was HighCape Capital, LLC’s latest transaction?
        HighCape Capital, LLC latest transaction was an Uninformative Sell of ―.
          What was HighCape Capital, LLC's most profitable transaction?
          HighCape Capital, LLC’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is HighCape Capital, LLC's role in Aziyo Biologics?
            HighCape Capital, LLC's role in Aziyo Biologics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.